Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China’s Gene Therapy Cancer Drugs: Great Science, Slow Acceptance

publication date: Dec 31, 2007

In a recent article, Bloomberg profiled Shanghai Sunway Biotech Co., detailing the career path of its founder, Dr. Hu Fang. The article uses the highly picturesque image of Hu’s career beginnings as a “barefoot doctor,” ordered at age 19 to the provinces to tend the rural population during the Great Leap Forward of the 1960s, sent without the benefit of medicines or instruments. Now, his career having advanced greatly, Hu heads a leading edge biotech company, one that has brought gene therapy to cancer drugs. Hu’s remarkable story serves as an apt illustration of the astonishing Great Leap Forward of China biotech in the last 15-20 years. More details...

Stock Symbols: (OTCBB:BPMA) (NDSQ: GENZ)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital